Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4)

被引:80
作者
Gonçalves, A [1 ]
Braguer, D [1 ]
Carles, G [1 ]
André, N [1 ]
Prevôt, C [1 ]
Briand, C [1 ]
机构
[1] Univ Mediterranee, Fac Pharm, UMR CNRS 6032, F-13005 Marseille 5, France
关键词
paclitaxel; antimicrotubule agents; apoptosis; caspase-8; CD95;
D O I
10.1016/S0006-2952(00)00481-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antimicrotubule agent-induced apoptosis was examined in the proliferating human colon cancer cell line HT29-D4. G2/M arrest and subsequent apoptosis were dose-dependent, both observed with 100 nM paclitaxel or docetaxel and 10 nM vinorelbine. Bcl-x(1), phosphorylation was observed simultaneously with mitotic block, then caspase-3 cleavage and poly(ADP-ribose) polymerase degradation were detected 48 hr later. By using both enzymatic assay and immunoblot detection of cleaved fragments, we showed that caspase-8, a central component of the CD95-induced apoptotic pathway, was significantly activated during paclitaxel exposure, contemporary to apoptosis occurrence. Caspase-8 activation and apoptosis were independent of CD95 ligation and evidenced only for concentrations inducing Bcl-x(L), phosphorylation and a decrease in mitochondria permeability. Similar results were obtained with docetaxel and vinca alkaloids. Thus, antimitotic drugs may induce apoptosis via caspase-8 activation independently of CD95/CD95-L. Caspase-8 may be a common mediator of anticancer drug-induced apoptosis that could represent a promising target for future therapies. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1579 / 1584
页数:6
相关论文
共 36 条
[1]  
ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147
[2]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[3]  
Bantel H, 1999, CANCER RES, V59, P2083
[4]  
Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO
[5]  
2-5
[6]   Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs [J].
Carles, G ;
Braguer, D ;
Dumontet, C ;
Bourgarel, V ;
Gonçalves, A ;
Sarrazin, M ;
Rognoni, JB ;
Briand, C .
BRITISH JOURNAL OF CANCER, 1999, 80 (08) :1162-1168
[7]   The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells [J].
Carles, G ;
Braguer, D ;
Sabeur, G ;
Briand, C .
ANTI-CANCER DRUGS, 1998, 9 (03) :209-221
[8]   The taxoids - Comparative clinical pharmacology and therapeutic potential [J].
Eisenhauer, EA ;
Vermorken, JB .
DRUGS, 1998, 55 (01) :5-30
[9]  
FANTINI J, 1986, J CELL SCI, V83, P235
[10]   Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis [J].
Ferrari, D ;
Stepczynska, A ;
Los, M ;
Wesselborg, S ;
Schulze-Osthoff, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :979-984